Lois FrankelSell
HAE · Transaction May 7, 2021 · Filed May 25, 2021 · $1,001 to $15,000
XNYS · HAE
+6.41% · +$5.79 · Vol Not reported
Pre-market · updated 04:02:50 ET
Haemonetics Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$96.06
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · HAE
MethodologyHAE
Haemonetics Corporation
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
STRONG
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
77/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is HAE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Haemonetics Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1991
Employees
3K
Country
US
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$90.27
Last session
Day high
$90.27
Last session
Day low
$90.27
Last session
Previous close
$90.27
52W high
$96.06
0.00% from high
52W low
$47.67
100% of range
Market cap
$4.1B
Beta
0.26
Shares out
45.5M
Avg volume
693.2K
VWAP
$90.27
Last session
Price history computed in-house
1W
+10.14%
1M
+23.38%
3M
+61.28%
1Y
+80.84%
YTD
+19.85%
SMA 50 $79.33 · above
SMA 200 $69.68 · above
52W position 100%
HAE overview
Related filings and maps
Public disclosures
Congress activity in HAE
Official filing ↗
Lois FrankelSell
HAE · Transaction May 6, 2021 · Filed May 25, 2021 · $1,001 to $15,000
Haemonetics Corporation · Transaction Jan 25, 2021 · Filed Feb 9, 2021 · $1,001 to $15,000
Haemonetics Corporation · Transaction Oct 16, 2020 · Filed Nov 5, 2020 · $1,001 to $15,000
Haemonetics Corporation · Transaction Sep 15, 2020 · Filed Oct 13, 2020 · $1,001 to $15,000
Federal contracts
HAE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HAE in this window.
Lobbying spend
HAE lobbying filings, year to date.
Registered lobbying filings matched to Haemonetics Corporation.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HAE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for HAE.
Options
Sovereign unlock shows live options positioning for HAE.